Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin®) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae
| Autor: | Robin Schaten, James Hedrick, Gerald W. Bottenfield, John T. Davies, Carolyn A. Rowinski, Daniel J. Burch |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Diarrhea
Male Microbiology (medical) medicine.medical_specialty medicine.drug_class Antibiotics Drug resistance Amoxicillin-Potassium Clavulanate Combination medicine.disease_cause Pneumococcal Infections Pharmacotherapy Double-Blind Method Internal medicine Clavulanic acid Streptococcus pneumoniae medicine Humans Child Antibacterial agent business.industry Infant Drug Resistance Microbial Amoxicillin Gastroenteritis Surgery Otitis Media Infectious Diseases Tolerability Child Preschool Acute Disease Pediatrics Perinatology and Child Health Drug Therapy Combination Female business medicine.drug |
| Zdroj: | The Pediatric Infectious Disease Journal. 17:963-968 |
| ISSN: | 0891-3668 |
| DOI: | 10.1097/00006454-199810000-00041 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|